Evidence map›Paper›PMID 35777702›Full record

ReviewThe Journal of hospital infection2022

Efficacy of biocidal agents and disinfectants against the monkeypox virus and other orthopoxviruses.

G Kampf

Abstract readReview
In one paragraph

Review in The Journal of hospital infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. The Biosafety Research Road Map: The Search for Evidence to Support Practices in the Laboratory-Mpox/Monkeypox Virus.Applied biosafety : journal of the American Biological Safety Association · 2023
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Heat inactivation of monkeypox virus.Journal of biosafety and biosecurity · 2022
    Article
  14. Article
  15. Monkeypox: An emerging zoonotic pathogen.World journal of virology · 2022
    Review
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

G KampfUniversity Medicine Greifswald, Greifswald, Germany. Electronic address: guenter.kampf@uni-greifswald.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The number of human monkeypox virus infections is increasing in many countries. The typical mode of transmission is by direct contact. As orthopoxviruses may stay infectious on inanimate surfaces under laboratory conditions for up to 42 days, disinfection may be relevant in the surroundings of confirmed cases. The aim of this review was to evaluate published data on the antiviral efficacy of biocidal agents and disinfectants against the monkeypox virus and other orthopoxviruses. A Medline search was carried out on 5

Indexed as

DisinfectantsMpox, MonkeypoxOrthopoxvirusVirusesAnimalsDisinfectionHumansMonkeypox virusDisinfectantsBiocidal agentDisinfectantEfficacyMonkeypox virusOrthopoxvirusVaccinia virus

Identifiers

PMID35777702
PMCPMC9534168

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.